Trials / Completed
CompletedNCT01101074
Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
A Prospective Observational Study of Safety and Effectiveness Following Administration of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135,469 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Accepted
Summary
This observational study will evaluate the safety and effectiveness following administration of adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine through both an ad hoc active monitoring system and a passive surveillance of hospitalization in a large cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is non-intervention observational study | This is non-intervention observational study |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-01-01
- Completion
- 2010-09-01
- First posted
- 2010-04-09
- Last updated
- 2011-10-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01101074. Inclusion in this directory is not an endorsement.